相关实验视频

Updated: May 13, 2025

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

Published on: May 5, 2023

异形性肺纤维化微环境:新的机制和研究方向

Fuguo Gao¹, Lei Pan¹, Wei Liu¹

¹Department of Pulmonary and Critical Care Medicine, Tangdu hospital, Air Force Medical University, Xi'an, 710038, China.

International immunopharmacology

|April 13, 2025

概括

异形性肺纤维化 (IPF) 研究探索其复杂的微环境,揭示细胞相互作用和信号通路. 介质细胞干细胞疗法对治疗这种渐进的肺部疾病充满希望.

科学领域:

肺部医学肺部医学
细胞生物学细胞生物学
分子生物学分子生物学

背景情况:

异形性肺纤维化 (IPF) 是一种严重的,进展性肺部疾病,其机制尚不清楚.
关键特征包括增加呼吸困难和呼吸衰竭,影响患者的生活质量.

研究的目的:

审查IPF微环境在疾病发病过程中的作用.
确定IPF的新机制和潜在的治疗点.

主要方法:

对研究IPF的细胞和分子方面进行的文献综述.
对IPF中的信号通路,非编码RNA和肺微生物群的分析.

主要成果:

细胞参与者 (上皮细胞,纤维细胞,免疫细胞) 和信号通路 (TGF-β,Wnt,mTOR,ROS) 在IPF进展中至关重要.
非编码RNAs,特别是miRNAs,是重要的生物标志物.
介酶干细胞 (MSC) 和它们的衍生物显示出治疗潜力.
肺部微生物群的改变与IPF有关.

结论:

IPF微环境对于疾病进展至关重要.
为了有效的IPF治疗,需要对MSC的疗法和其他微环境调制进行进一步的研究.
了解这些复杂的相互作用可能会改善患者的治疗结果.

关键词:

细胞外囊泡中的细胞外囊泡.异形性肺纤维化症异形性肺纤维化症肺部的微生物群.微观环境是一个微观环境.信号通道的信号通道.干细胞是一种干细胞.

更多相关视频

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization

Published on: January 20, 2023

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Introduction to Fibroblasts

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...